Treatment-naïve HPV+ head and neck cancers display a T-cell-inflamed phenotype distinct from their HPV- counterparts that has implications for immunotherapy.

Gameiro, Steven F; Ghasemi, Farhad; Barrett, John W; Koropatnick, James; Nichols, Anthony C; Mymryk, Joe S; Maleki Vareki, Saman

Gameiro, Steven F; Ghasemi, Farhad; Barrett, John W; Koropatnick, James; Nichols, Anthony C; Mymryk, Joe S; Maleki Vareki, Saman.

Afiliación

Gameiro SF; Department of Microbiology and Immunology, The University of Western Ontario, London, ON, Canada.
Ghasemi F; Department of Otolaryngology, Head & Neck Surgery, The University of Western Ontario, London, ON, Canada.
Barrett JW; Department of Otolaryngology, Head & Neck Surgery, The University of Western Ontario, London, ON, Canada.
Koropatnick J; Department of Microbiology and Immunology, The University of Western Ontario, London, ON, Canada.
Nichols AC; Department of Oncology, The University of Western Ontario, London, ON, Canada.
Mymryk JS; Department of Pathology, The University of Western Ontario, London, ON, Canada.
Maleki Vareki S; Department of Physiology and Pharmacology, The University of Western Ontario, London, ON, Canada.

Oncoimmunology ; 7(10): e1498439, 2018.

Article en En | MEDLINE | ID: mdl-30288365

Palabras clave

head and neck cancer; human papillomavirus; immune checkpoint markers; survival; tumour infiltrating lymphocytes

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Oncoimmunology Año: 2018 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google